Ulf Eriksson group

Members and a selection of publications from the Ulf Eriksson Group.


Ulf Eriksson

C2 Department of Medical Biochemistry and Biophysics

Research Group

Selected publications

Mice Lacking Platelet-Derived Growth Factor D Display a Mild Vascular Phenotype.
Gladh H, Folestad EB, Muhl L, Ehnman M, Tannenberg P, Lawrence AL, et al
PLoS ONE 2016 ;11(3):e0152276

Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.
Lewandowski SA, Fredriksson L, Lawrence DA, Eriksson U
Pharmacol. Ther. 2016 11;167():108-119

Presymptomatic activation of the PDGF-CC pathway accelerates onset of ALS neurodegeneration.
Lewandowski SA, Nilsson I, Fredriksson L, Lönnerberg P, Muhl L, Zeitelhofer M, et al
Acta Neuropathol. 2016 Mar;131(3):453-64

PGC-1α Coordinates Mitochondrial Respiratory Capacity and Muscular Fatty Acid Uptake via Regulation of VEGF-B.
Mehlem A, Palombo I, Wang X, Hagberg CE, Eriksson U, Falkevall A
Diabetes 2016 04;65(4):861-73

Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
Falkevall A, Mehlem A, Palombo I, Heller Sahlgren B, Ebarasi L, He L, et al
Cell Metab. 2017 03;25(3):713-726

Neuropilin 1 binds PDGF-D and is a co-receptor in PDGF-D-PDGFRβ signaling.
Muhl L, Folestad EB, Gladh H, Wang Y, Moessinger C, Jakobsson L, et al
J. Cell. Sci. 2017 04;130(8):1365-1378

Content reviewer:
Sara Lidman